Inhibition of adamts13: a novel therapy to treat mechanical circulatory support-induced acquired von willebrand syndrome

Back

ESC Premium Access

Inhibition of adamts13: a novel therapy to treat mechanical circulatory support-induced acquired von willebrand syndrome

Session: Role of Platelets, Inflammation and Endothelial Cells in Vascular Dysfunction

Topic: Drugs, Drug Targets

Speaker: Doctor S. Deconinck (Kortrijk, BE)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Shannen Deconinck

Laboratory for Thrombosis Research, Kortrijk (Belgium)

1 presentation

0 follower

6 more presentations in this session

A novel whole blood coagulometer for NOAC testing

Speaker: Doctor S. Bakhru (Danbury, US)

Access

Abstract

Slides

Heparin is more effective than apixaban in inhibiting in vitro contact activated coagulation

Speaker: Doctor M. Engelen (Leuven, BE)

Access

Abstract

Slides

Selatogrel, the reversible and specific P2Y12 receptor antagonist, does not interfere with haemostasis

Speaker: Doctor M. Riederer (Allschwil, CH)

Access

Abstract

Slides

Shear stress induced activation of von Willebrand factor may predispose to gastrointestinal bleeding in syndrome of Heyde

Speaker: Mrs Y. Avtaeva (Moscow, RU)

Access

Abstract

Slides

Aquaporin-1: a major modulator of aging-mediated platelet/endothelial dysfunction in atherothrombosis

Speaker: Doctor S. Saeedi (Schlieren, CH)

Access

Abstract

Slides

Access the full session

Role of Platelets, Inflammation and Endothelial Cells in Vascular Dysfunction

Speakers: Doctor S. Deconinck, Doctor S. Bakhru, Doctor M. Engelen, Doctor M. Riederer, Mrs Y. Avtaeva...

Access

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources